Recombinant protein vaccines against the asexual blood-stages of<i>Plasmodium falciparum</i>

Abstract excerpt

It is now more than 25 years since asexual blood stage antigens of Plasmodium falciparum were first expressed as recombinant proteins. Although many asexual blood stage vaccine candidates have been identified, none has yet been fully evaluated in clinical trials. The results of studies in animal models, and from in vitro studies with P. falciparum, indicate that antibody responses induced by many of these...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Malaria Research and Control
• Share to vaccines and immunoinformatics approaches
• Share to Vector-borne infectious diseases